Lanean...
BNT162b2 mRNA COVID-19 Vaccine: First Approval
BNT162b2 (Comirnaty(®); BioNTech and Pfizer) is a lipid nanoparticle-formulated, nucleoside-modified mRNA vaccine for the prevention of the novel coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. BNT162b2 encodes the SARS-CoV-2 spik...
Gorde:
| Argitaratua izan da: | Drugs |
|---|---|
| Egile nagusia: | |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Springer International Publishing
2021
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7938284/ https://ncbi.nlm.nih.gov/pubmed/33683637 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40265-021-01480-7 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|